Deltagen

Representation of biotech company Deltagen in its chapter 11 case in the Northern District of California. The company developed knockout mice and related phenotypic, genotypic, and other data and information that it licensed to academic and commercial customers worldwide for research and development purposes. The company confirmed a plan of reorganization that repaid all of its unsecured creditors in full and reinstated all outstanding shareholder interests.